Value proposition

Next Big Innovation Labs® is a Deep Tech Lifesciences platform, developing 3D Bioprinting Technology and Products

Next Big Innovations Labs (NBIL) is a startup of enthusiastic individuals on a mission to confront the world’s most challenging problems in the healthcare space.
We are a research driven startup working on a novel approach to tackle the current muddle vexing the pharmaceutical, clinical and cosmetic R&D sectors. We feel we can crack these problems only by using the disruptive technology of 3D Bioprinting. At NBIL, we focus to solve the organ availability crisis plaguing the entire globe using 3D Bioprinting; aiming to create a world where the abyss between organ demand and availability for organ transplantation is bridged by in-vitro organogenesis.

3D Bioprinting, Tissue Regeneration, Regenerative Medicine, Pharmaceutical R&D, Cosmetic R&D, Clinical R&D, 3D Printing, Scaffold Printing, Biomaterials, and 3D Bioprinters